EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Michelle A Josephson, Yolanda Becker, Klemens Budde, Bertram L Kasiske, Bryce A Kiberd, Alexandre Loupy, Jolanta Małyszko, Roslyn B Mannon, Burkhard Tönshoff, Michael Cheung, Michel Jadoul, Wolfgang C Winkelmayer und 2 weitere

Kidney International · 2023-12 · 104 (6) · 1076-1091

DOI: 10.1016/j.kint.2023.05.010 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Kidney International, 2023-12. Verfasst von Michelle A Josephson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Section of Nephrology, Department of Medicine, and Transplant Institute, University of Chicago, Chicago, Illinois, USA. Electronic address: mjosephs@…. Hauptthemen laut MEDLINE: Kidney, Kidney Diseases. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In March 2022, Kidney Disease: Improving Global Outcomes (KDIGO) held a virtual Controversies Conference to address the important but rarely examined phase during which the kidney transplant is failing or has failed. In addition to discussing the definition of a failing allograft, 4 broad areas were considered in the context of a declining functioning graft: prognosis and kidney failure trajectory; immunosuppression strategies; management of medical and psychological complications, and patient factors; and choice of kidney replacement therapy or supportive care following graft loss. Identifying and paying special attention to individuals with failing allografts was felt to be important in order to prepare patients psychologically, manage immunosuppression, address complications, prepare for dialysis and/or retransplantation, and transition to supportive care. Accurate prognostication tools, although not yet widely available, were embraced as necessary to define allograft survival trajectories and the likelihood of allograft failure. The decision of whether to withdraw or continue immunosuppression after allograft failure was deemed to be based most appropriately on risk-benefit analysis and likelihood of retransplantation within a few months. Psychological preparation and support was identified as a critical factor in patient adjustment to graft failure, as was early communication. Several models of care were noted that enabled a medically supportive transition back to dialysis or retransplantation. Emphasis was placed on the importance of dialysis-access readiness before initiation of dialysis, in order to avoid use of central venous catheters. The centrality of the patient to all management decisions and discussions was deemed to be paramount. Patient "activation," which can be defined as engaged agency, was seen as the most effective way to achieve success. Unresolved controversies, gaps in knowledge, and areas for research were also stressed in the conference deliberations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KidneyKidney DiseasesHumansTransplantation, HomologousRenal DialysisAllografts

Stichwörter der Autor:innen

dialysisfailing/failed graftimmunosuppressionmedical complicationspsychological complicationsretransplantation

Autor:innen und Institutionen

  • Section of Nephrology, Department of Medicine, and Transplant Institute, University of Chicago, Chicago, Illinois, USA. Electronic address: mjosephs@bsd.uchicago.edu.
  • Transplantation Institute, Department of Surgery, University of Chicago, Chicago, Illinois, USA.
  • Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Medicine, Hennepin Healthcare, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, F-75015 Paris, France; Department of Kidney Transplantation, Necker Hospital, Assistance Publique - Hôpitaux de Paris, Pari…

Zitieren

APA

Josephson, M. A., Becker, Y., Budde, K., Kasiske, B. L., Kiberd, B. A., Loupy, A., Małyszko, J., Mannon, R. B., Tönshoff, B., Cheung, M., Jadoul, M., Winkelmayer, W. C., Zeier, M., & for Conference Participants (2023). Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 104(6), 1076-1091. https://doi.org/10.1016/j.kint.2023.05.010

Vancouver

Josephson MA, Becker Y, Budde K, Kasiske BL, Kiberd BA, Loupy A, et al. Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 2023;104(6):1076-1091. doi:10.1016/j.kint.2023.05.010

BibTeX
@article{Josephson2023,
  author = {Josephson, Michelle A and Becker, Yolanda and Budde, Klemens and Kasiske, Bertram L and Kiberd, Bryce A and Loupy, Alexandre and Małyszko, Jolanta and Mannon, Roslyn B and Tönshoff, Burkhard and Cheung, Michael and Jadoul, Michel and Winkelmayer, Wolfgang C and Zeier, Martin and for Conference Participants, for Conference Participants},
  title = {Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference},
  journal = {Kidney International},
  year = {2023},
  volume = {104},
  number = {6},
  pages = {1076--1091},
  doi = {10.1016/j.kint.2023.05.010}
}
Kostenlos starten →